
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load
Author(s) -
Veronica Miller,
Caroline Sabin,
Andrew Phillips,
Carsten Rottmann,
Holger F. Rabenau,
Eckard Weidmann,
Volker Rickerts,
Stephan Findhammer,
E. B. Helm,
Schlomo Staszewski
Publication year - 2000
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-200009290-00009
Subject(s) - viral load , medicine , protease inhibitor (pharmacology) , poisson regression , immunology , proportional hazards model , viral disease , antiretroviral therapy , human immunodeficiency virus (hiv) , population , environmental health
To compare the rate of disease progression according to viral load and CD4 cell count in patients receiving or not receiving highly active antiretroviral therapy (HAART), defined as protease inhibitor-containing regimens.